Kay M M, Rapcsak S Z, Bosman G J, Goodman J R
Dept. of Microbiology and Immunology, Veterans Administration Research Service, University of Arizona College of Medicine, Tucson 85724-5049, USA.
Cell Mol Biol (Noisy-le-grand). 1996 Nov;42(7):919-44.
Band 3 performs the same structural and functional activities in adult brain as it does in erythrocytes. It ages as cells and tissues age Our studies, to date, indicate that the anion transport ability of band 3 decreases in brains and lymphocytes from old mice. This decreased transport ability precedes obvious structural changes, such as band 3 degradation and generation of SCA and is the earliest change thus far detected in band 3. The following changes occur in lymphocytes, erythrocytes and brain band 3 with aging: 1) a decreased efficiency of anion transport (decreased Vmax) in spite of an increase in number of anion binding sites (increased K(m)), 2) a decreased glucose transport, 3) 32P labeling in vitro, 4) an increased degradation to smaller fragments as detected by quantitative binding of antibodies to band 3 breakdown products and residue 812-830, and 5) a binding of physiologic IgG autoantibodies in situ. The latter three findings indicate that posttranslational changes occur. In addition, the anion transporter, band 3, undergoes an as yet undefined change that results in binding of "980" antibodies to aged band 3. Posttranslational changes in AD include decreased brain and RBC phosphorylation of a M(r) = 135, 113 and 45 kDa band 3 polypeptides due to the phosphorylation site being already occupied, increased degradation of band 3, alterations in band 3 recognized by antibodies, and decreased anion and glucose transport by blood cells. Band 3 in erythrocytes of AD patients has a different immunological identity from normal band 3 as evidenced by the binding of antibodies described in this study. AD may be preferentially manifested in the brain because neurons accumulate damage throughout the lifetime as they do not regenerate or undergo cell division. We suspect, and our data indicate, that the same mechanism(s) of AD occurs in all cells, but that the manifestations differ due to different cell proteins and functions.
带3在成人大脑中执行的结构和功能活动与其在红细胞中执行的相同。它会随着细胞和组织的衰老而老化。我们目前的研究表明,老年小鼠大脑和淋巴细胞中带3的阴离子转运能力下降。这种转运能力下降先于明显的结构变化,如带3降解以及淀粉样β蛋白前体裂解酶和淀粉样蛋白的产生,并且是迄今为止在带3中检测到的最早变化。随着衰老,淋巴细胞、红细胞和大脑中的带3会发生以下变化:1)尽管阴离子结合位点数量增加(米氏常数增加),但阴离子转运效率降低(最大反应速度降低);2)葡萄糖转运减少;3)体外32P标记;4)通过抗体与带3降解产物和残基812 - 830的定量结合检测到,降解为更小片段的情况增加;5)生理IgG自身抗体原位结合。后三个发现表明发生了翻译后变化。此外,阴离子转运蛋白带3经历了一种尚未明确的变化,导致“980”抗体与老化的带3结合。阿尔茨海默病中的翻译后变化包括大脑和红细胞中分子量为135、113和45 kDa的带3多肽磷酸化减少,原因是磷酸化位点已被占据,带3降解增加,抗体识别的带3发生改变,以及血细胞的阴离子和葡萄糖转运减少。本研究中描述的抗体结合证明,阿尔茨海默病患者红细胞中的带3具有与正常带3不同的免疫特性。阿尔茨海默病可能在大脑中优先表现出来,因为神经元在整个生命周期中积累损伤,因为它们不会再生或进行细胞分裂。我们怀疑并且我们的数据表明,阿尔茨海默病的相同机制发生在所有细胞中,但由于不同的细胞蛋白质和功能,表现有所不同。